Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle ...

Continuous Glucose Monitoring (CGM) devices make it easy to keep your health in check despite seasonal changes, without the ...

Control-IQ+ is easy to start, use, and personalize, and this latest integration works with the FreeStyle Libre 3 Plus sensor and extends its benefits to even more people with diabetes.

Insulet has launched a humorous paid social campaign for its wearable Omnipod 5 insulin delivery system -- and teamed with Marvel for a stigma-busting comic book starring a teen heroine with diabetes.

The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent ...

The strategy and product exec said Tandem aims to give patients options and reach more people who haven’t yet used insulin ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX ...

Two experts discuss why more research is needed before continuous glucose monitors can be used reliably for insulin ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

Tandem Diabetes' t:slim X2 pump with Control-IQ+ tech gains U.S. early access using FreeStyle Libre 3 Plus sensor.

Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings. They should maintain their dividend growth habits ...